| Names | |
|---|---|
|
IUPAC name
2-(Acetylamino)-glutaramidic acid
|
|
| Other names | |
| Identifiers | |
|
3D model (JSmol)
|
|
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.017.862 |
| EC Number | 219-647-7 |
| KEGG | |
| MeSH | aceglutamide |
|
PubChem CID
|
|
| UNII | |
|
|
|
|
| Properties | |
| C7H12N2O4 | |
| Molar mass | 188.18 g·mol−1 |
| Appearance | White crystals |
| Melting point | 197 °C (387 °F; 470 K) |
| Related compounds | |
|
Related alkanoic acids
|
|
|
Related compounds
|
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Aceglutamide (brand name Neuramina), or aceglutamide aluminum (brand name Glumal), also known as acetylglutamine, is a psychostimulant, nootropic, and antiulcer agent that is marketed in Spain and Japan. It is an acetylated form of the amino acid L-glutamine, the precursor of glutamate in the body and brain. Aceglutamide functions as a prodrug to glutamine with improved potency and stability. Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminum is used in the treatment of ulcers. Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition. The drug has shown neuroprotective effects in an animal model of cerebral ischemia.